Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M M Strijbis

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's DiseaseMarcus W Koch, Lorraine V Kalia, Justyna Sarna, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2022
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple SclerosisFloor C Loonstra, Lodewijk R J de Ruiter, Marleen J A Koel-Simmelink, et al.
Neurology|June 17, 2026
Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple SclerosisLonneke Bos, Alle Meije Wink, James H Cole, et al.
Frontiers in Neurology|September 5, 2022
The association between blood MxA mRNA and long-term disease activity in early multiple sclerosisEline M E Coerver, Eva M M Strijbis, Laura F Petzold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2012
Glutamate gene polymorphisms predict brain volumes in multiple sclerosisEva M M Strijbis, Becky Inkster, Maria Vounou, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 24, 2023
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosisAlyssa A Toorop, Laura Hogenboom, Karien Bloem, et al.
Nature Reviews. Neurology|July 23, 2025
Advancing multiple sclerosis management in older adultsAnneke van der Walt, Eva M M Strijbis, Francesca Bridge, et al.
Neuroimage. Clinical|October 8, 2024
Scanner-specific optimisation of automated lesion segmentation in MSDavid R van Nederpelt, Giuseppe Pontillo, Mar Barrantes-Cepas, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R J de Ruiter, Floor C Loonstra, Julia R Jelgerhuis, et al.
Neurology|April 23, 2025
Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease SeverityDavid Rudolf van Nederpelt, Lonneke Bos, Rozemarijn M Mattiesing, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's DiseaseMarcus W Koch, Lorraine V Kalia, Justyna Sarna, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2022
Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple SclerosisFloor C Loonstra, Lodewijk R J de Ruiter, Marleen J A Koel-Simmelink, et al.
Neurology|June 17, 2026
Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple SclerosisLonneke Bos, Alle Meije Wink, James H Cole, et al.
Frontiers in Neurology|September 5, 2022
The association between blood MxA mRNA and long-term disease activity in early multiple sclerosisEline M E Coerver, Eva M M Strijbis, Laura F Petzold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2012
Glutamate gene polymorphisms predict brain volumes in multiple sclerosisEva M M Strijbis, Becky Inkster, Maria Vounou, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 24, 2023
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosisAlyssa A Toorop, Laura Hogenboom, Karien Bloem, et al.
Nature Reviews. Neurology|July 23, 2025
Advancing multiple sclerosis management in older adultsAnneke van der Walt, Eva M M Strijbis, Francesca Bridge, et al.
Neuroimage. Clinical|October 8, 2024
Scanner-specific optimisation of automated lesion segmentation in MSDavid R van Nederpelt, Giuseppe Pontillo, Mar Barrantes-Cepas, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohortLodewijk R J de Ruiter, Floor C Loonstra, Julia R Jelgerhuis, et al.
Neurology|April 23, 2025
Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease SeverityDavid Rudolf van Nederpelt, Lonneke Bos, Rozemarijn M Mattiesing, et al.
Pageof 6